A National Cancer Institute-designated Comprehensive Cancer Center

Make an appointment: 800-826-HOPE
Biostatistics Core Facility Bookmark and Share

Biostatistics Core Facility

Director: Jeffrey Longmate, Ph.D.
Co-Director: David Smith, Ph.D.

The Biostatistics Core facility draws upon a group of statisticians who collaborate in basic, translational, clinical and population research in the City of Hope Comprehensive Cancer Center. The Core is supported by City of Hope’s NCI-funded Cancer Center Support Grant (CCSG), with additional institutional support.  Its services are available to all City of Hope and Beckman researchers.
 
Areas of expertise include:  Basic science:  statistical methods for assays and bioassays, animal models, genomics (RNA-seq, CHIP-seq, microarray, rRNA microbial classification), mutation spectra, experimental genetics; Translational science:  animal models, xenografts, cell migration, statistics for toxicology, pharmacokinetic modeling; Clinical Science:  clinical trials, diagnostics, biomarkers, retrospective clinical studies, clinical epidemiology; Population Science: Epidemiology, genetic epidemiology; General:  numerical and graphical data summary, statistical inference, and prediction models.
 
Research Roles: Core members can help with study design, grant proposals, clinical protocols, data analysis, and manuscripts.

Services

Collaboration in research intended for publication is our main activity.  Contact any core statistician, or contact the director for an introduction (email: #biostat_core).
 
Consulting is available to advise investigators on statistical issues in research, or to explore possible collaboration.  This is often simply a collegial interaction, but investigators may contact the director (email: #biostat_core) for an introduction to a statistician.  Consulting generally consists of one or two meetings, and it’s always free.  Early contact about research planning is always welcomed.
 
Case finding: The core can provide HIPAA-compliant identification of patients with stored tissue samples or other clinical and disease characteristics.  (email: #case_finding; phone ext. 32002 or 61444)
 
Statistical Computing is provided in conjunction with collaboration.  The core does not provide user-directed computing, and does not operate a help desk for statistical software.
 
Data extraction from various COH and public databases is provided in conjunction with collaboration, but is not provided as a separate service.
 
To access services or to use the facility, please contact us at 626-256-HOPE (4673), ext. 61444 or via email (#biostat_core or jlongmate@coh.org).
 
Research reported in this publication included work performed in the Biostatistics Core supported by the National Cancer Institute of the National Institutes of Health under award number P30CA33572. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.
 

Abstract for Grants

Note:  Proposals including a statistician as a collaborator will ordinarily include a biosketch, and possibly a letter of collaboration.  For proposals in which a statistician has a small, defined role, funding for core support may be included as an expense, in which case you may wish to contact the collaborating statistician or the director for a letter of support.  The following generic statement is provided as a resource, but please contact the Biostatistics Core if you use it.
 
The Biostatistics Core is a shared resource of the City of Hope Comprehensive Cancer Center.  It draws upon 10 doctoral-level statisticians and 6 staff statisticians.  Members of the Biostatistics Core collaborate in basic, translational, clinical and population research, and its services are available to all City of Hope researchers.  Research areas supported include: bioassay, animal models, genomics, genetics, mutation, toxicology, pharmacokinetics, diagnostics, biomarkers, clinical trials, clinical epidemiology; population epidemiology, genetic epidemiology.  In general, the core can provide standard and principled approaches to numerical and graphical data summary, statistical inference, modeling, and prediction. Core members help with study design, grant proposals, clinical protocols, data analysis, and manuscripts.  Statistical software includes SAS, R, StatXact, EaST, and NQuery Advisor.  A linux cluster is available for computationally intensive projects, and COH has excellent network and IT support.
 

Using the Facility

The core encourages collaboration, so investigators are free to contact faculty statisticians directly. You can request an introduction or consulting appointment by phone (ext 61444) or email (#biostat_core).

Any publication involving the use of core services should arrange for submission of the publication to PubMed Central, in compliance with the NIH Public Access Policy, and should include the following acknowledgement:
 
Research reported in this publication included work performed in the Biostatistics Core supported by the National Cancer Institute of the National Institutes of Health under award number P30CA33572. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.
 
It is also generally accepted practice that a collaborating statistician from the core will be included in the authorship list if the research is presented in a public forum or published. Authorship is unrelated to funding.

Pricing

Funding core effort:
 
Consulting refers to one-on-one meetings with Core statisticians to discuss the statistical approaches necessary for the research. Consulting is free, but intended primarily for advice and initial planning discussions.
 
Collaborative projects should fund a statistician’s effort in one of the following ways:
 
Grants:  Include appropriate statistician support in the personnel budget.  
Contracts:  Include appropriate statistician effort in the contract.
Clinical trials: Include appropriate statistician effort in the clinical trials finance budget.
Portfolio studies are those for which a department or investigator has arranged for statistical support from specific core personnel, similar to a grant budget.
Other Studies generally require that statistician effort is supported by the investigator via core charges.
Analysis of Data for Publication – (e.g. a novel or unanticipated statistical need) may be left to the statistician’s discretion and availability.
 
Case finding for Letters of Intent (LOIs) is a free service.  Investigators may use iCode for self-service. Case finding for all other uses may be charged at the published core rates.

Other activities: Occasionally, the Biostatistics Core is asked to assist with data extraction or similar activities that are not a core service, not research, or not collaborative.  If such a request is accepted, it will be billed at full cost-recovery (external) rates. 
 
Hourly Charge Rates:
  CCSG Members Internal Users External Users
Staff Biostatisticians $45.00 $50.00 $89.00
PhD/RSO Statisicians $67.50 $75.00 $136.00

 
 

Biostatistics Core Directors

Jeffrey Longmate, Ph.D.
Director
626-256-HOPE (4673), 62478
jlongmate@coh.org

David Smith, Ph.D.
Co-Director
626-256-HOPE (4673)
dsmith02@coh.org
 
Location
City of Hope and Beckman Research Institute
1500 East Duarte Road
Duarte, CA  91010-3000
 
Information Sciences Building (#171)
Phone:  626-256-HOPE (4673), Ext. 61444
Fax:  626-471-7106 or 626-301-8802
 

Biostatistics Core Directors

Biostatistics Core Facility

Biostatistics Core Facility

Director: Jeffrey Longmate, Ph.D.
Co-Director: David Smith, Ph.D.

The Biostatistics Core facility draws upon a group of statisticians who collaborate in basic, translational, clinical and population research in the City of Hope Comprehensive Cancer Center. The Core is supported by City of Hope’s NCI-funded Cancer Center Support Grant (CCSG), with additional institutional support.  Its services are available to all City of Hope and Beckman researchers.
 
Areas of expertise include:  Basic science:  statistical methods for assays and bioassays, animal models, genomics (RNA-seq, CHIP-seq, microarray, rRNA microbial classification), mutation spectra, experimental genetics; Translational science:  animal models, xenografts, cell migration, statistics for toxicology, pharmacokinetic modeling; Clinical Science:  clinical trials, diagnostics, biomarkers, retrospective clinical studies, clinical epidemiology; Population Science: Epidemiology, genetic epidemiology; General:  numerical and graphical data summary, statistical inference, and prediction models.
 
Research Roles: Core members can help with study design, grant proposals, clinical protocols, data analysis, and manuscripts.

Services

Collaboration in research intended for publication is our main activity.  Contact any core statistician, or contact the director for an introduction (email: #biostat_core).
 
Consulting is available to advise investigators on statistical issues in research, or to explore possible collaboration.  This is often simply a collegial interaction, but investigators may contact the director (email: #biostat_core) for an introduction to a statistician.  Consulting generally consists of one or two meetings, and it’s always free.  Early contact about research planning is always welcomed.
 
Case finding: The core can provide HIPAA-compliant identification of patients with stored tissue samples or other clinical and disease characteristics.  (email: #case_finding; phone ext. 32002 or 61444)
 
Statistical Computing is provided in conjunction with collaboration.  The core does not provide user-directed computing, and does not operate a help desk for statistical software.
 
Data extraction from various COH and public databases is provided in conjunction with collaboration, but is not provided as a separate service.
 
To access services or to use the facility, please contact us at 626-256-HOPE (4673), ext. 61444 or via email (#biostat_core or jlongmate@coh.org).
 
Research reported in this publication included work performed in the Biostatistics Core supported by the National Cancer Institute of the National Institutes of Health under award number P30CA33572. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.
 

Abstract for Grants

Abstract for Grants

Note:  Proposals including a statistician as a collaborator will ordinarily include a biosketch, and possibly a letter of collaboration.  For proposals in which a statistician has a small, defined role, funding for core support may be included as an expense, in which case you may wish to contact the collaborating statistician or the director for a letter of support.  The following generic statement is provided as a resource, but please contact the Biostatistics Core if you use it.
 
The Biostatistics Core is a shared resource of the City of Hope Comprehensive Cancer Center.  It draws upon 10 doctoral-level statisticians and 6 staff statisticians.  Members of the Biostatistics Core collaborate in basic, translational, clinical and population research, and its services are available to all City of Hope researchers.  Research areas supported include: bioassay, animal models, genomics, genetics, mutation, toxicology, pharmacokinetics, diagnostics, biomarkers, clinical trials, clinical epidemiology; population epidemiology, genetic epidemiology.  In general, the core can provide standard and principled approaches to numerical and graphical data summary, statistical inference, modeling, and prediction. Core members help with study design, grant proposals, clinical protocols, data analysis, and manuscripts.  Statistical software includes SAS, R, StatXact, EaST, and NQuery Advisor.  A linux cluster is available for computationally intensive projects, and COH has excellent network and IT support.
 

Using the Facility

Using the Facility

The core encourages collaboration, so investigators are free to contact faculty statisticians directly. You can request an introduction or consulting appointment by phone (ext 61444) or email (#biostat_core).

Any publication involving the use of core services should arrange for submission of the publication to PubMed Central, in compliance with the NIH Public Access Policy, and should include the following acknowledgement:
 
Research reported in this publication included work performed in the Biostatistics Core supported by the National Cancer Institute of the National Institutes of Health under award number P30CA33572. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.
 
It is also generally accepted practice that a collaborating statistician from the core will be included in the authorship list if the research is presented in a public forum or published. Authorship is unrelated to funding.

Pricing

Pricing

Funding core effort:
 
Consulting refers to one-on-one meetings with Core statisticians to discuss the statistical approaches necessary for the research. Consulting is free, but intended primarily for advice and initial planning discussions.
 
Collaborative projects should fund a statistician’s effort in one of the following ways:
 
Grants:  Include appropriate statistician support in the personnel budget.  
Contracts:  Include appropriate statistician effort in the contract.
Clinical trials: Include appropriate statistician effort in the clinical trials finance budget.
Portfolio studies are those for which a department or investigator has arranged for statistical support from specific core personnel, similar to a grant budget.
Other Studies generally require that statistician effort is supported by the investigator via core charges.
Analysis of Data for Publication – (e.g. a novel or unanticipated statistical need) may be left to the statistician’s discretion and availability.
 
Case finding for Letters of Intent (LOIs) is a free service.  Investigators may use iCode for self-service. Case finding for all other uses may be charged at the published core rates.

Other activities: Occasionally, the Biostatistics Core is asked to assist with data extraction or similar activities that are not a core service, not research, or not collaborative.  If such a request is accepted, it will be billed at full cost-recovery (external) rates. 
 
Hourly Charge Rates:
  CCSG Members Internal Users External Users
Staff Biostatisticians $45.00 $50.00 $89.00
PhD/RSO Statisicians $67.50 $75.00 $136.00

 
 

Contact Us

Biostatistics Core Directors

Jeffrey Longmate, Ph.D.
Director
626-256-HOPE (4673), 62478
jlongmate@coh.org

David Smith, Ph.D.
Co-Director
626-256-HOPE (4673)
dsmith02@coh.org
 
Location
City of Hope and Beckman Research Institute
1500 East Duarte Road
Duarte, CA  91010-3000
 
Information Sciences Building (#171)
Phone:  626-256-HOPE (4673), Ext. 61444
Fax:  626-471-7106 or 626-301-8802
 

Biostatistics Core Facility Directors

Biostatistics Core Directors

Research Shared Services

City of Hope embodies the spirit of scientific collaboration by sharing services and core facilities with colleagues here and around the world.
 

Recognized nationwide for its innovative biomedical research, City of Hope's Beckman Research Institute is home to some of the most tenacious and creative minds in science.
City of Hope is one of only 41 Comprehensive Cancer Centers in the country, the highest designation awarded by the National Cancer Institute to institutions that lead the way in cancer research, treatment, prevention and professional education.
Learn more about City of Hope's institutional distinctions, breakthrough innovations and collaborations.
Support Our Research
By giving to City of Hope, you support breakthrough discoveries in laboratory research that translate into lifesaving treatments for patients with cancer and other serious diseases.
 
 
 
 
Media Inquiries/Social Media
 
CONNECT WITH US
Facebook  Twitter  YouTube  Blog
 


NEWS & UPDATES
  • To say that myelofibrosis patients need more treatment options would be an understatement. The severely low platelet counts, known as thrombocytopenia, that are one of the hallmark symptoms of the disease can lead to chronic fatigue and weakness that not only damage quality of life but, ultimately, shorten life...
  • Patients with metastatic colorectal cancer often stop responding to the primary drugs used against the disease, leaving them with few options and little hope. Determined to increase those options, doctors and researchers at City of Hope are conducting two clinical trials that could lead to new treatments for pe...
  • Investigators working at City of Hope are making many significant inroads against many forms of cancer. To do that, they have to take a variety of approaches. Molecular oncology researchers focus on abnormal cancer-associated activity in a cell’s nucleus. One especially prominent factor in many breast and ovari...
  • In light of the new breast cancer screening guidelines, which call for women to have mammograms every other year from age 50 to 74, it’s more important than ever for women to understand their individual risk. On Monday, the U.S. Preventive Services Task force released new breast cancer screening guideline...
  • Cancer patients need, and deserve, more than medical care. They and their families need high-quality supportive care – that is, care that addresses their physical, emotional and spiritual well-being. Health care professionals increasingly understand this, but starting such programs from scratch isn’t easy...
  • Each year, City of Hope patients given another chance at life gather to pose for a picture like this one. Going on its 39th year, the celebration of patients free of blood cancers thanks to bone marrow or stem cell transplants has grown such that a photographer has to scale a cherry picker just to […]
  • Cancer patients who are participating in early-stage clinical trials need extra emotional and physical support due to their additional stress and often unique symptoms. Now an effort by researchers at City of Hope to create a model for such support has received a $6.8 million grant from the National Cancer Inst...
  • The need for improvements in treating malignant brain tumors has never been greater. Survival for many patients with these tumors are sometimes measured in just months. One reason that therapeutic options are limited is that traditional surgery is deemed too risky for many brain tumors, especially for those in ...
  • “Honestly, there’s nothing special about my story,” protested Daniel Samson, as he bounced Layla, his 3 1/2-year-old daughter, on his lap and put on a video for her to watch. “I just want to tell it for my own sake, and share it with other men who may be going through this chaos.” Samson spoke […]
  • As far back as he can remember, Jonathan Yamzon, M.D., wanted to be a doctor. “I knew it from the get-go,” he said, matter-of-factly. “I always envisioned it as the ideal; the supreme thing one could do with one’s life.” The youngest of six children, Yamzon was barely a toddler when his family moved to [&...
  • There’s never a “good” time for cancer to strike. With testicular cancer, the timing can seem particularly unfair. This disease targets young adults in the prime of life; otherwise healthy people unaccustomed to any serious illness, let alone cancer. And suddenly … “I can only imagine what they must...
  • Sure, a healthy lifestyle can lower a person’s risk, but the impact of specific actions is harder to tease out. Diet, exercise, tobacco use, nutritional supplements, alcohol consumption … How important are each of these factors, individually? Does strict adherence to (or rejection of) one get you a pass o...
  • Health care decisions are tough. They’re even tougher when you – or loved ones – have to make them without a plan or a conversation. National Healthcare Decisions Day, on April 16,  is a nationwide initiative to demystify the health care decision-making process and encourage families to start talking. Ult...
  • The statistics, direct from the American Cancer Society, are sobering: Cancer death rates among African-American men are 27 percent higher than for white men. The death rate for African-American women is 11 percent higher compared to white women. Hispanics have higher rates of cervical, liver and stomach cancer...
  • “Lucky” is not usually a term used to describe someone diagnosed with cancer.  But that’s how 34-year-old Alex Camargo’s doctor described him when he was diagnosed with thyroid cancer — the disease is one of the most treatable cancers at all stages. That doctor was ultimately proved righ...